{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/16/3312598/0/en/Entera-Reports-Robust-Preclinical-Data-for-EB612-Oral-LA-PTH-1-34-for-Hypoparathyroidism-and-EB618-Oral-GLP-1-Glucagon-for-Obesity-at-ENDO-2026.html", "message": "News view counter 801726 successfully enlarged"}